Home The Word Brain | My Amedeo FAQ Privacy About | ||||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
HIV Infection |
Free Subscription
5 AIDS |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO HIV Infection is free of charge.
Transition to dolutegravir-based ART in 35 low- and middle-income countries: a
global survey of HIV care clinics.
AIDS. 2024 Sep 5. doi: 10.1097/QAD.0000000000004007.
PubMed
Abstract available
Changes in HIV Pre-exposure Prophylaxis Awareness and Use Among Males Who Inject
Drugs Who Have Sex with Men by Sexual Identity, 19 US Urban Areas, 2018 & 2022.
AIDS. 2024 Sep 3. doi: 10.1097/QAD.0000000000004005.
PubMed
Abstract available
Primary HPV screening compared with other cervical cancer screening strategies in
women with HIV: a cost-effectiveness study.
AIDS. 2024 Sep 2. doi: 10.1097/QAD.0000000000004002.
PubMed
Abstract available
Low food security is associated with frailty status and frailty components among
people with HIV.
AIDS. 2024 Sep 4. doi: 10.1097/QAD.0000000000004006.
PubMed
Abstract available
Perinatal exposure to HIV leaves a lasting neurocognitive mark - even when
vertical transmission is prevented.
AIDS. 2024 Sep 2. doi: 10.1097/QAD.0000000000004004.
PubMed
Rosalind Franklin Society Proudly Announces the 2023 Award Recipient for AIDS
Research and Human Retroviruses.
AIDS Res Hum Retroviruses. 2024;40:501.
PubMed
Comparing Two-Step Approaches to Measuring Gender Identity: The Reliability and
Applications of Asking About Sex Assigned at Birth versus Transgender
Self-Identification.
Am J Epidemiol. 2024 Sep 3:kwae341. doi: 10.1093.
PubMed
Abstract available
Bridged Treatment Comparisons: an Illustrative Application in HIV Treatment.
Am J Epidemiol. 2024 Aug 31:kwae340. doi: 10.1093.
PubMed
Abstract available
Discovery of new acetamide derivatives of 5-indole-1,3,4-oxadiazol-2-thiol as
inhibitors of HIV-1 Tat-mediated viral transcription.
Antimicrob Agents Chemother. 2024 Sep 4:e0064324. doi: 10.1128/aac.00643.
PubMed
Abstract available
Design of novel and highly selective SARS-CoV-2 main protease inhibitors.
Antimicrob Agents Chemother. 2024 Sep 3:e0056224. doi: 10.1128/aac.00562.
PubMed
Abstract available
DEFINE: A Prospective, Randomized, Phase 4 Trial to Assess a Protease
Inhibitor-based Regimen Switch Strategy to Manage Integrase Inhibitor-related
Weight Gain.
Clin Infect Dis. 2024 Sep 4:ciae449. doi: 10.1093.
PubMed
Abstract available
Lipid and glucose profiles in pregnant women with HIV on tenofovir-based
antiretroviral therapy.
Clin Infect Dis. 2024 Sep 2:ciae441. doi: 10.1093.
PubMed
Abstract available
Evaluation of HIV antiretroviral treatment adherence in 2019 using anonymized
data from the French national health insurance claims data base: The COCOVIH
study.
HIV Med. 2024 Sep 5. doi: 10.1111/hiv.13690.
PubMed
Abstract available
Real-world effectiveness and safety of switching to dolutegravir/lamivudine among
people living with HIV-1 aged over 50 years who are virologically suppressed.
HIV Med. 2024 Sep 6. doi: 10.1111/hiv.13699.
PubMed
Abstract available
Therapeutic failure reported with HIV long-acting injectables: An analysis of the
FDA Adverse Event Reporting System from 2021 to 2024.
HIV Med. 2024 Sep 5. doi: 10.1111/hiv.13709.
PubMed
Abstract available
Trajectories of CD4 T-cell count, CD8 T-cell count, and CD4/CD8 ratio in patients
with HIV and long-term virological suppression based on Yunnan HIV cohort.
HIV Med. 2024 Sep 2. doi: 10.1111/hiv.13707.
PubMed
Abstract available
HIV-1 Elite Controllers are Characterised by Elevated Levels of CD69-Expressing
Natural Killer Cells.
J Acquir Immune Defic Syndr. 2024 Sep 2. doi: 10.1097/QAI.0000000000003518.
PubMed
Abstract available
Elevated Plasma Matrix Metalloproteinases Are Associated With Mycobacterium
tuberculosis Bloodstream Infection and Mortality in Human Immunodeficiency
Virus-Associated Tuberculosis.
J Infect Dis. 2024 Sep 2:jiae296. doi: 10.1093.
PubMed
Abstract available
Association Between SARS-CoV-2 Viral Load and COVID-19 Vaccination in 4 Phase 3
Trials.
J Infect Dis. 2024 Sep 3:jiae400. doi: 10.1093.
PubMed
Abstract available
In depth analysis of the HIV reservoir confirms effectiveness and safety of
DTG/3TC in a phase 4 randomized controlled switch trial (RUMBA).
J Infect Dis. 2024 Sep 3:jiae405. doi: 10.1093.
PubMed
Abstract available
N121T and N121S substitutions on the SARS-CoV-2 spike protein impact on serum
neutralization.
J Med Virol. 2024;96:e29871.
PubMed
Abstract available
Short CDRL1 in intermediate VRC01-like mAbs is not sufficient to overcome key
glycan barriers on HIV-1 Env.
J Virol. 2024 Sep 6:e0074424. doi: 10.1128/jvi.00744.
PubMed
Abstract available
Three families of CD4-induced antibodies are associated with the capacity of
plasma from people living with HIV to mediate ADCC in the presence of
CD4-mimetics.
J Virol. 2024 Sep 4:e0096024. doi: 10.1128/jvi.00960.
PubMed
Abstract available
Breadth and polyfunctionality of T cell responses to human cytomegalovirus in men
who have sex with men: relationship with HIV infection and frailty.
J Virol. 2024 Sep 4:e0116724. doi: 10.1128/jvi.01167.
PubMed
Abstract available
HIV and tuberculosis in Uganda: are we neglecting poverty?
Lancet. 2024;404:844-845.
PubMed
Sustained HIV remission after allogeneic hematopoietic stem cell transplantation
with wild-type CCR5 donor cells.
Nat Med. 2024 Sep 2. doi: 10.1038/s41591-024-03277.
PubMed
Abstract available
HIV: how close are we to a vaccine - or a cure?
Nature. 2024 Sep 2. doi: 10.1038/d41586-024-02840.
PubMed
Viral load suppression and HIV-1 drug resistance mutations in persons with HIV on
TLD/TAFED in Zambia.
PLoS One. 2024;19:e0308869.
PubMed
Abstract available
The evolutionary and transmission dynamics of HIV-1 CRF08_BC.
PLoS One. 2024;19:e0310027.
PubMed
Abstract available
Predicting neutralization susceptibility to combination HIV-1 monoclonal broadly
neutralizing antibody regimens.
PLoS One. 2024;19:e0310042.
PubMed
Abstract available
Cost-effectiveness of pretreatment HIV drug resistance testing in people living
with HIV in Iran.
PLoS One. 2024;19:e0309528.
PubMed
Abstract available
Are children of key population individuals at higher risk of HIV than other
children? Results from a multi-country analysis of routine program data.
PLoS One. 2024;19:e0309847.
PubMed
Abstract available
Effects of the timing of maternal antiretroviral therapy initiation, CD4 count,
and HIV viral load on birth outcomes in the Eastern Cape province of South
Africa: A secondary data analysis.
PLoS One. 2024;19:e0308374.
PubMed
Abstract available
The relationship between selected sexually transmitted pathogens, HPV and HIV
infection status in women presenting with gynaecological symptoms in Maputo City,
Mozambique.
PLoS One. 2024;19:e0307781.
PubMed
Abstract available
Chinese herbal medicine for patients living with HIV in Guangxi province, China:
A propensity score matching analysis of real-world data.
PLoS One. 2024;19:e0304332.
PubMed
Abstract available
Determinants of care-seeking behavior for sexually transmitted infections among
sexually active men in East Africa: A multilevel mixed effect analysis.
PLoS One. 2024;19:e0307755.
PubMed
Abstract available
Persistent hypertension among postpartum women with comorbid HIV and preeclampsia
in Zambia.
PLoS One. 2024;19:e0309915.
PubMed
Abstract available
Concurrent disease burden from multiple infectious diseases and the influence of
social determinants in the contiguous United States.
PLoS One. 2024;19:e0293431.
PubMed
Abstract available
Prevalence and factors associated with external HIV-related stigma in the South
African population: Results from the 2017 population-based household survey.
PLoS One. 2024;19:e0309694.
PubMed
Abstract available
HIV-1 residual risk and pre-treatment drug resistance among blood donors: A
sentinel surveillance from Gabon.
PLoS One. 2024;19:e0305935.
PubMed
Abstract available
The HIV-1 capsid serves as a nanoscale reaction vessel for reverse transcription.
PLoS Pathog. 2024;20:e1011810.
PubMed
Abstract available
Structural and virologic mechanism of the emergence of resistance to M(pro)
inhibitors in SARS-CoV-2.
Proc Natl Acad Sci U S A. 2024;121:e2404175121.
PubMed
Abstract available
Thank you for your interest in scientific medicine.